iPharmaCenter

Putting patients at center

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Home

  • COVID-19

  • News

  • Conferences

  • Healthcare Policies & Systems

  • Regional News

    • North America
    • Europe
    • APAC
  • Patient info

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • TraditionalHealthcare
    • Healthcare Systems
    • News
    • Conferences
    • Know your disease
    • COVID
    • Japan drug approvals
    • USA Pharma News | Healthcare News
    • Europe Pharma News
    • Japan drug approvals
    • Australia Pharma & Healthcare News
    • Canada Pharma and Healthcare News
    • Asia | Pharma | Healthcare News
    • Indication News
    Search
    China Drug Approvals | NMPA Drug Approvals | Pharma | Healthcare | China
    ipharmaservices
    • Apr 14

    China Drug Approvals | NMPA Drug Approvals | Pharma | Healthcare | China

    0
    Japan Pharma and Healthcare News | Blogs | iPharmaCenter
    ipharmaservices
    • Jan 31

    Japan Pharma and Healthcare News | Blogs | iPharmaCenter

    0
    Australia Healthcare News | Drug reimbursement
    ipharmaservices
    • Jan 30

    Australia Healthcare News | Drug reimbursement

    0
    Australia Drug Approvals | Drugs approved by TGA
    ipharmaservices
    • Jan 27

    Australia Drug Approvals | Drugs approved by TGA

    0
    COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
    ipharmaservices
    • Jan 2

    COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

    0
    China released the 2022 NDRL list, Chinese pharma benefited from the list
    ipharmaservices
    • Dec 3, 2021

    China released the 2022 NDRL list, Chinese pharma benefited from the list

    0
    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
    ipharmaservices
    • Nov 3, 2021

    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

    0
    WHO granted EUL to Covaxin; acclaims easy storage requirement
    ipharmaservices
    • Nov 3, 2021

    WHO granted EUL to Covaxin; acclaims easy storage requirement

    0
    Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
    ipharmaservices
    • Mar 12, 2021

    Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

    0
    Expected best selling pharmaceutical products (drugs) in 2021
    ipharmaservices
    • Jan 20, 2021

    Expected best selling pharmaceutical products (drugs) in 2021

    0
    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
    ipharmaservices
    • Jan 12, 2021

    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

    0
    Bayer submitted vericiguat for market authorization in China
    ipharmaservices
    • Aug 28, 2020

    Bayer submitted vericiguat for market authorization in China

    0
    Bayer’s Xofigo received approval for prostate cancer in China
    ipharmaservices
    • Aug 27, 2020

    Bayer’s Xofigo received approval for prostate cancer in China

    0
    Merck’s Keytruda received one more indication and dosage form approval in Japan
    ipharmaservices
    • Aug 25, 2020

    Merck’s Keytruda received one more indication and dosage form approval in Japan

    0
    AZ received one more approval in Japan, received approval of Imfinzi for SCLC
    ipharmaservices
    • Aug 22, 2020

    AZ received one more approval in Japan, received approval of Imfinzi for SCLC

    0
    JAPAN HEALTHCARE SYSTEM
    ipharmaservices
    • Aug 17, 2020

    JAPAN HEALTHCARE SYSTEM

    0
    ipharmaservices
    • Aug 12, 2020

    China’s National Medicinal Products Administration approved Gilead’s Truvada

    0
    ipharmaservices
    • Jul 9, 2020

    Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

    0
    ipharmaservices
    • Jun 23, 2020

    Merck’s Keytruda approved in China for esophageal squamous cell carcinoma

    0
    ipharmaservices
    • Jun 23, 2020

    GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial

    0
    1
    2

    Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

    For any further updates, contact us at ipharmaservices@gmail.com

    ©2022 by ipharmaservices